Related Experiment Video
Updated: Jul 24, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Malignancy risk in patients with atopic dermatitis: a population-based cohort study
Joy Wan1, Daniel B Shin2, Maha N Syed2
1Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
This study found no overall increased cancer risk in children and adults with atopic dermatitis (AD). However, severe AD was linked to a higher risk of lymphoma, and mild AD to nonmelanoma skin cancer.
Area of Science:
- Dermatology and Oncology
- Epidemiology
- Immunodermatology
Background:
- Atopic dermatitis (AD) involves immune dysfunction, potentially impacting cancer development.
- Previous research on AD and cancer yields inconsistent findings, with limited data on pediatric populations or AD severity.
- Understanding the relationship between AD severity, treatment, and malignancy risk is crucial.
Purpose of the Study:
- To investigate the association between atopic dermatitis (AD) and the risk of developing various malignancies in both children and adults.
- To analyze how AD severity, categorized by treatment and specialist referrals, influences specific cancer risks.
- To provide updated epidemiological evidence on AD and cancer risk in a large cohort.
Main Methods:
- A UK-based cohort study utilized electronic health records from 1994-2015.
- Children and adults with AD were matched to controls without AD, with AD severity classified as mild, moderate, or severe.
- Primary outcome was incident malignancy (all types), with secondary outcomes including specific cancers like leukemia, lymphoma, melanoma, and nonmelanoma skin cancer (NMSC).
Main Results:
- In children, overall malignancy risk was similar between AD and control groups; however, severe AD correlated with increased lymphoma risk, and mild AD with increased NMSC risk.
- In adults, overall malignancy risk was not significantly different, but severe AD showed a twofold higher risk for non-cutaneous T-cell lymphoma (non-CTCL).
- AD was associated with a slight increase in overall skin cancer risk and a slight decrease in solid cancer risk, with variations based on specific cancer types and AD severity.
Conclusions:
- Current epidemiological data do not indicate a substantial overall increase in malignancy risk associated with atopic dermatitis (AD).
- Severe AD may be linked to an elevated risk of lymphoma, particularly non-CTCL in adults.
- Further research may clarify the nuanced relationship between AD severity, specific cancer types, and immunological factors.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cancer Prevention
Some...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

